Institutional Investors Show Diverging Views on IBM Stock

Major funds show divided sentiment on IBM after earnings beat. Some boosted holdings by over 275%, while others cut positions. Analysts maintain a Moderate Buy rating.

Recent regulatory filings reveal a clear split in sentiment among major investment firms toward International Business Machines Corp. (IBM). While some institutions significantly increased their holdings following the company's latest earnings report, others chose to reduce their exposure, painting a picture of divided institutional opinion.

Earnings Performance Drives Activity

The catalyst for this reshuffling appears to be IBM's robust fourth-quarter 2025 results. The technology giant reported quarterly earnings per share of $4.52, surpassing the consensus estimate of $4.33. Revenue for the period showed strong growth, climbing 12.2% to reach $19.69 billion.

This financial performance has prompted contrasting moves from fund managers. On the buying side, Worth Asset Management LLC boosted its IBM position by 277% during the quarter, bringing its total holding to 6,084 shares. Similarly, Cypress Wealth Services LLC increased its stake by 187%, accumulating 5,330 shares.

Conversely, other institutions trimmed their portfolios. Advisors Management Group reduced its IBM holdings by 12.5%, leaving it with 34,498 shares. Chesley Taft & Associates executed a 16.5% cut, decreasing its position to 16,067 shares.

Insider Purchases and Analyst Outlook

Adding another layer to the investment thesis, recent insider transactions have signaled confidence from within the company itself. Board member David N. Farr acquired 1,000 shares in late January at a price of $304.00 per share. Director Michael Miebach purchased 434 shares in late February at $233.33 each.

The current analyst consensus for IBM stock stands at "Moderate Buy." This rating is supported by eleven "Buy" recommendations, one "Strong Buy," and eight "Hold" ratings. Market experts have established an average price target of $314.60, suggesting substantial upside potential from current trading levels. Looking ahead to the full 2026 fiscal year, analysts are projecting earnings per share of $10.78.

Valuation Context

IBM's shares currently trade approximately 14% below their 200-day moving average. This valuation gap may help explain the divergent strategies emerging among institutional investors, as some see a buying opportunity while others remain cautious. The mixed activity underscores the ongoing debate regarding the stock's near-term trajectory in light of its recent financial achievements.